Why should we take care about occupational dosimetric impact when routine use of gallium-68 in nuclear medicine ? A preliminary study

Autor: Varmenot, N., Ferrer, L., Frindel, M., Rauscher, A., Baumgartner, P., Delaunay, F., Mathey, A., Pitel, C., Zulian, H., Kraeber-Bodere, F., Denis, A., Rousseau, C.

Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2018, 45 (1), pp.S81-S82
European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 (1), pp.S81-S82
Web of Science

International audience; Introduction: Medical research in PET/CT diagnosis involving new gallium-68 radiolabelled pharmaceuticals is steadily rising in the last years thanks to the combined improvement of both radionuclide production and radiolabelli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d876ac8434f5278c656060a1dc9e9d27
https://www.hal.inserm.fr/inserm-02344327/document